Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis

NCT05058417 is registered in ClinicalTrials.gov with Sadat City University as lead sponsor.

NCT NCT05058417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05058417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis
Lead sponsor
Sadat City University
Phase
Phase 2
Overall status
Withdrawn
Start date
October 1, 2021
Completion date
December 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis